RGEN
REPLIGEN CORP
Company overview
- Market capitalization
- $10.95B
- Employees
- 2,000
- Latest publication
- 2026-09-29
About REPLIGEN CORP
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 204,128,000USD | 194,255,000USD | 197,913,000USD | 188,805,000USD | 182,366,000USD | 169,172,000USD | 154,073,000USD | 153,182,000USD |
| Cost Of Revenue | 94,091,000USD | 95,771,000USD | 104,470,000USD | 88,290,000USD | 91,224,000USD | 78,415,000USD | 85,300,000USD | 76,391,000USD |
| Gross Profit | 110,037,000USD | 98,484,000USD | 93,443,000USD | 100,515,000USD | 91,142,000USD | 90,757,000USD | 68,773,000USD | 76,791,000USD |
| Research Development | 14,417,000USD | 14,458,000USD | 12,184,000USD | 14,175,000USD | 13,958,000USD | 12,924,000USD | 10,575,000USD | 11,238,000USD |
| Selling General Administrative | 76,618,000USD | 76,536,000USD | 86,000,000USD | 73,663,000USD | 71,227,000USD | 71,255,000USD | 64,697,000USD | 60,986,000USD |
| Total Operating Expenses | 96,061,000USD | 80,494,000USD | 74,887,000USD | 83,690,000USD | 77,246,000USD | 84,179,000USD | 75,272,000USD | 73,041,000USD |
| Operating Income | 13,976,000USD | 17,990,000USD | 18,556,000USD | 16,825,000USD | 13,896,000USD | 6,578,000USD | 1,487,000USD | 3,750,000USD |
| Total Other Income Expense Net | 177,000USD | -16,218,000USD | 557,000USD | 287,000USD | 4,319,000USD | 1,365,000USD | 3,695,000USD | -55,000USD |
| Interest Expense | 5,663,000USD | 5,997,000USD | 5,912,000USD | 27,449,000USD | 5,768,000USD | 5,663,000USD | 5,501,000USD | 5,512,000USD |
| Income Before Tax | 14,153,000USD | 1,772,000USD | 19,113,000USD | 17,112,000USD | 18,215,000USD | 7,943,000USD | 5,182,000USD | 3,695,000USD |
| Income Tax Expense | 9,145,000USD | -6,561,000USD | 5,826,000USD | 2,201,000USD | 3,349,000USD | 2,113,000USD | 1,861,000USD | 399,000USD |
| Net Income | 5,008,000USD | 8,333,000USD | 13,287,000USD | 14,911,000USD | 14,866,000USD | 5,830,000USD | 3,321,000USD | 3,296,000USD |
| Unclassified Operating Expenses | — | -10,500,000USD | -23,297,000USD | -4,148,000USD | -7,939,000USD | — | — | — |
| Net Interest Income | — | -5,997,000USD | -5,912,000USD | -5,830,000USD | -5,768,000USD | -5,663,000USD | -5,501,000USD | -5,374,000USD |
| Tax Provision | — | -6,561,000USD | 5,826,000USD | 2,201,000USD | 3,349,000USD | 2,113,000USD | 1,861,000USD | 20,000USD |
| Net Income From Continuing Ops | — | 8,333,000USD | 13,287,000USD | 14,911,000USD | 14,866,000USD | 5,830,000USD | 3,321,000USD | 2,094,000USD |
| Ebit | — | 7,769,000USD | 25,025,000USD | 22,526,000USD | 23,569,000USD | 13,193,000USD | 10,683,000USD | 8,724,000USD |
| Ebitda | — | 32,306,000USD | 44,977,000USD | 46,936,000USD | 48,335,000USD | 36,381,000USD | 27,440,000USD | 30,027,000USD |
| Depreciation And Amortization | — | 24,537,000USD | 19,952,000USD | 24,410,000USD | 24,766,000USD | 23,188,000USD | 16,757,000USD | 21,303,000USD |
| Reconciled Depreciation | — | 24,537,000USD | 24,592,000USD | 24,410,000USD | 24,766,000USD | 23,188,000USD | 16,857,000USD | 16,791,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 817,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 738,256,000USD | 638,764,000USD | 801,536,000USD | 670,534,000USD | 366,260,000USD | 270,245,000USD | 194,032,000USD | 141,236,000USD |
| Cost Of Revenue | 390,632,000USD | 354,517,000USD | 345,830,000USD | 279,280,000USD | 171,905,000USD | 132,020,000USD | 85,953,000USD | 67,050,000USD |
| Gross Profit | 347,624,000USD | 284,247,000USD | 455,706,000USD | 391,254,000USD | 194,355,000USD | 138,225,000USD | 108,079,000USD | 74,186,000USD |
| Research Development | 54,177,000USD | 42,722,000USD | 43,936,000USD | 34,274,000USD | 19,657,000USD | 19,450,000USD | 15,768,000USD | 8,672,000USD |
| Selling General Administrative | 290,508,000USD | 213,838,000USD | 215,829,000USD | 183,866,000USD | 119,621,000USD | 95,613,000USD | 65,692,000USD | 51,509,000USD |
| Unclassified Operating Expenses | -56,639,000USD | -26,294,000USD | -28,729,000USD | 5,865,000USD | -26,211,000USD | -16,921,000USD | — | — |
| Total Operating Expenses | 288,046,000USD | 230,266,000USD | 231,036,000USD | 224,005,000USD | 113,067,000USD | 98,142,000USD | 82,091,000USD | 60,181,000USD |
| Operating Income | 59,578,000USD | 54,576,000USD | 224,670,000USD | 167,249,000USD | 81,288,000USD | 40,083,000USD | 25,988,000USD | 14,005,000USD |
| Interest Expense | 23,173,000USD | 10,026,000USD | 2,977,000USD | 12,714,000USD | 12,133,000USD | 9,292,000USD | 6,709,000USD | 6,441,000USD |
| Net Interest Income | -23,173,000USD | -2,911,000USD | -2,977,000USD | -12,714,000USD | -12,133,000USD | -9,292,000USD | -6,709,000USD | -6,441,000USD |
| Income Before Tax | 62,383,000USD | 64,132,000USD | 219,140,000USD | 153,543,000USD | 59,217,000USD | 26,151,000USD | 21,436,000USD | 7,248,000USD |
| Income Tax Expense | 13,489,000USD | 22,555,000USD | 33,181,000USD | 25,252,000USD | -709,000USD | 4,740,000USD | 4,819,000USD | -21,105,000USD |
| Tax Provision | 13,489,000USD | 10,081,000USD | 33,181,000USD | 25,252,000USD | -709,000USD | 4,740,000USD | 4,819,000USD | -21,105,000USD |
| Net Income | 48,894,000USD | 41,577,000USD | 185,959,000USD | 128,291,000USD | 59,926,000USD | 21,411,000USD | 16,617,000USD | 28,353,000USD |
| Net Income From Continuing Ops | 48,894,000USD | 115,794,000USD | 185,959,000USD | 128,291,000USD | 59,926,000USD | 21,411,000USD | 16,617,000USD | 28,353,000USD |
| Ebit | 85,556,000USD | 56,207,000USD | 220,302,000USD | 164,821,000USD | 71,350,000USD | 35,443,000USD | 25,988,000USD | 13,689,000USD |
| Ebitda | 164,302,000USD | 124,292,000USD | 277,314,000USD | 203,268,000USD | 98,417,000USD | 56,311,000USD | 41,766,000USD | 24,141,000USD |
| Depreciation And Amortization | 78,746,000USD | 68,085,000USD | 57,012,000USD | 38,447,000USD | 27,067,000USD | 20,868,000USD | 15,778,000USD | 10,452,000USD |
| Reconciled Depreciation | 96,956,000USD | 65,322,000USD | 50,985,000USD | 38,447,000USD | 27,067,000USD | 20,868,000USD | 15,778,000USD | 10,507,000USD |
| Total Other Income Expense Net | 2,805,000USD | 9,556,000USD | -5,530,000USD | -13,706,000USD | -22,071,000USD | -13,932,000USD | -4,552,000USD | -6,757,000USD |
| Non Operating Income Net Other | — | — | -4,368,000USD | -992,000USD | 1,527,000USD | -640,000USD | 2,157,000USD | -316,000USD |
| Net Income Applicable To Common Shares | — | — | 185,959,000USD | 128,291,000USD | 59,926,000USD | 21,411,000USD | 16,617,000USD | 28,353,000USD |
| Interest Income | — | — | — | — | — | 3,968,000USD | 4,814,000USD | 6,070,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | 631,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 2,950,180,000USD | 2,930,772,000USD | 2,949,699,000USD | 2,923,711,000USD | 2,901,627,000USD | 2,852,143,000USD | 2,829,666,000USD | 2,830,644,000USD |
| Cash And Equivalents | 606,783,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 810,449,000USD | 784,531,000USD | 767,628,000USD | 748,747,000USD | 708,855,000USD | 697,229,000USD | 757,355,000USD | 783,964,000USD |
| Short Term Investments | 203,666,000USD | 201,881,000USD | 201,607,000USD | — | — | — | 0USD | — |
| Total Current Assets | 1,200,554,000USD | 1,161,360,000USD | 1,137,385,000USD | 1,096,485,000USD | 1,056,865,000USD | 1,032,465,000USD | 1,066,041,000USD | 1,131,570,000USD |
| Other Current Assets | 45,791,000USD | 46,021,000USD | 40,712,000USD | 38,448,000USD | 35,196,000USD | 34,713,000USD | 31,607,000USD | 36,115,000USD |
| Other Non Current Assets | 4,049,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 838,148,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 132,656,000USD | 126,209,000USD | 135,826,000USD | 131,136,000USD | 123,012,000USD | 151,996,000USD | 126,787,000USD | 108,366,000USD |
| Other Current Liabilities | 77,080,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 17,090,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 2,112,032,000USD | 2,105,463,000USD | 2,106,129,000USD | 2,083,087,000USD | 2,061,741,000USD | 1,985,483,000USD | 1,972,718,000USD | 2,016,686,000USD |
| Total Equity Including Noncontrolling Interest | 2,112,032,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 19,598,000USD | — | — | — | — | — | — | — |
| Net Receivables | 157,710,000USD | 151,552,000USD | 158,587,000USD | 148,970,000USD | 156,952,000USD | 147,413,000USD | 134,115,000USD | 129,026,000USD |
| Inventory | 186,604,000USD | 179,256,000USD | 170,458,000USD | 160,320,000USD | 155,862,000USD | 153,110,000USD | 142,964,000USD | 182,465,000USD |
| Property Plant Equipment Net | 283,072,000USD | 287,105,000USD | 306,152,000USD | 313,088,000USD | 321,171,000USD | 325,190,000USD | 333,116,000USD | 329,851,000USD |
| Goodwill | 1,104,183,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 357,622,000USD | 368,188,000USD | 386,147,000USD | 395,442,000USD | 406,213,000USD | 409,225,000USD | 397,897,000USD | 380,754,000USD |
| Accounts Payable | 33,233,000USD | 34,657,000USD | 30,010,000USD | 29,426,000USD | 25,625,000USD | 26,935,000USD | 32,134,000USD | 21,357,000USD |
| Short Term Debt | 19,318,000USD | 21,071,000USD | 21,559,000USD | 19,314,000USD | 16,043,000USD | 15,154,000USD | 15,104,000USD | 12,171,000USD |
| Common Stock | 564,000USD | 564,000USD | 563,000USD | 563,000USD | 563,000USD | 562,000USD | 561,000USD | 560,000USD |
| Retained Earnings | 469,589,000USD | 464,581,000USD | 456,248,000USD | 442,961,000USD | 428,050,000USD | 413,184,000USD | 407,354,000USD | 441,223,000USD |
| Accumulated Other Comprehensive Income | -19,786,000USD | -14,309,000USD | -2,531,000USD | -4,107,000USD | -1,716,000USD | -47,841,000USD | -52,533,000USD | -34,623,000USD |
| Total Liab | — | 825,309,000USD | 843,570,000USD | 840,624,000USD | 839,886,000USD | 866,660,000USD | 856,948,000USD | 813,958,000USD |
| Other Current Liab | — | 52,173,000USD | 69,648,000USD | 66,715,000USD | 59,130,000USD | 88,698,000USD | 64,883,000USD | 58,244,000USD |
| Capital Stock | — | 564,000USD | 563,000USD | 563,000USD | 563,000USD | 562,000USD | 561,000USD | 560,000USD |
| Good Will | — | 1,106,874,000USD | 1,114,408,000USD | 1,112,735,000USD | 1,114,009,000USD | 1,082,413,000USD | 1,030,995,000USD | 987,620,000USD |
| Cash | — | 582,650,000USD | 566,021,000USD | 748,747,000USD | 708,855,000USD | 697,229,000USD | 757,355,000USD | 783,964,000USD |
| Current Deferred Revenue | — | 18,308,000USD | 14,609,000USD | 15,681,000USD | 20,806,000USD | 21,209,000USD | 13,243,000USD | 16,446,000USD |
| Net Debt | — | 104,970,000USD | 123,927,000USD | -59,880,000USD | -22,791,000USD | -13,531,000USD | -71,108,000USD | -111,493,000USD |
| Short Long Term Debt Total | — | 687,620,000USD | 689,948,000USD | 688,867,000USD | 686,064,000USD | 683,698,000USD | 686,247,000USD | 672,471,000USD |
| Long Term Debt | — | 546,585,000USD | 542,213,000USD | 537,927,000USD | 533,725,000USD | 529,605,000USD | 525,567,000USD | 521,607,000USD |
| Property Plant Equipment Gross | — | 287,105,000USD | 510,034,000USD | 506,672,000USD | 504,812,000USD | 497,138,000USD | 495,583,000USD | 482,975,000USD |
| Common Stock Shares Outstanding | — | 56,666,000shares | 56,521,739shares | 56,520,000shares | 56,509,198shares | 56,558,072shares | 56,056,993shares | 56,940,000shares |
| Non Current Assets Total | — | 1,769,412,000USD | 1,812,314,000USD | 1,827,226,000USD | 1,844,762,000USD | 1,819,678,000USD | 1,763,625,000USD | 1,699,074,000USD |
| Non Current Liabilities Total | — | 699,099,999USD | 707,744,000USD | 709,488,000USD | 716,874,000USD | 714,664,000USD | 730,161,000USD | 705,592,000USD |
| Non Current Liabilities Other | — | 17,533,000USD | 16,859,000USD | 19,800,000USD | 23,527,000USD | 21,984,000USD | 36,243,000USD | 11,606,000USD |
| Non Currrent Assets Other | — | 3,893,000USD | 4,913,000USD | 5,105,000USD | 2,569,000USD | 2,113,000USD | 868,000USD | 748,000USD |
| Net Working Capital | — | 1,035,151,000USD | 1,001,559,000USD | 965,349,000USD | 933,853,000USD | 880,469,000USD | 939,254,000USD | 1,023,204,000USD |
| Unclassified Non Current Liabilities | — | 134,981,999USD | 148,672,000USD | 151,761,000USD | 159,622,000USD | 163,075,000USD | 168,351,000USD | 172,379,000USD |
| Unclassified Equity | — | 1,654,063,000USD | 1,651,286,000USD | 1,643,107,000USD | 1,634,281,000USD | 1,619,016,000USD | 1,616,775,000USD | 1,608,966,000USD |
| Other Assets | — | — | — | 2,174,964,000USD | — | — | 282,077,000USD | — |
| Unclassified Non Current Assets | — | — | — | -2,174,108,000USD | — | — | -281,328,000USD | — |
| Unclassified Current Liabilities | — | — | — | — | 1,408,000USD | — | 1,423,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 2,949,699,000USD | 2,829,666,000USD | 2,824,411,000USD | 2,531,600,000USD | 2,358,354,000USD | 1,902,887,000USD | 1,400,113,000USD | 288,913,000USD |
| Intangible Assets | 386,147,000USD | 397,897,000USD | 400,486,000USD | 360,618,000USD | 337,274,000USD | 287,100,000USD | 212,552,000USD | 29,806,000USD |
| Other Current Assets | 40,712,000USD | 31,607,000USD | 33,238,000USD | 19,837,000USD | 25,949,000USD | 18,676,000USD | 14,932,000USD | 628,000USD |
| Total Liab | 843,570,000USD | 856,948,000USD | 853,208,000USD | 620,900,000USD | 608,287,000USD | 373,737,000USD | 340,345,000USD | 120,149,000USD |
| Total Stockholder Equity | 2,106,129,000USD | 1,972,718,000USD | 1,971,203,000USD | 1,910,700,000USD | 1,750,067,000USD | 1,529,150,000USD | 1,059,768,000USD | 168,764,000USD |
| Other Current Liab | 69,648,000USD | 66,306,000USD | 46,415,000USD | 63,328,000USD | 55,839,000USD | 36,344,000USD | 24,452,000USD | 15,606,000USD |
| Common Stock | 563,000USD | 561,000USD | 558,000USD | 556,000USD | 553,000USD | 548,000USD | 521,000USD | 338,000USD |
| Capital Stock | 563,000USD | 561,000USD | 558,000USD | 556,000USD | 553,000USD | 548,000USD | 521,000USD | — |
| Retained Earnings | 456,248,000USD | 407,354,000USD | 438,849,000USD | 397,272,000USD | 194,060,000USD | 65,769,000USD | 5,843,000USD | -59,861,000USD |
| Good Will | 1,114,408,000USD | 1,030,995,000USD | 987,120,000USD | 855,513,000USD | 860,362,000USD | 618,305,000USD | 468,413,000USD | 59,548,000USD |
| Cash | 566,021,000USD | 757,355,000USD | 751,323,000USD | 523,458,000USD | 603,814,000USD | 717,292,000USD | 528,392,000USD | 141,780,000USD |
| Cash And Short Term Investments | 767,628,000USD | 757,355,000USD | 751,323,000USD | 623,757,000USD | 603,814,000USD | 717,292,000USD | 528,392,000USD | 141,780,000USD |
| Total Current Assets | 1,137,385,000USD | 1,066,041,000USD | 1,111,043,000USD | 998,118,000USD | 931,677,000USD | 902,382,000USD | 641,828,000USD | 184,153,000USD |
| Total Current Liabilities | 135,826,000USD | 126,787,000USD | 158,162,000USD | 404,196,000USD | 375,262,000USD | 318,956,000USD | 48,313,000USD | 21,075,000USD |
| Current Deferred Revenue | 14,609,000USD | 13,243,000USD | 10,287,000USD | 19,283,000USD | 14,675,000USD | 15,318,000USD | 5,005,000USD | 408,000USD |
| Net Debt | 123,927,000USD | -71,108,000USD | -39,519,000USD | -100,497,000USD | -237,761,000USD | -441,876,000USD | -265,073,000USD | -46,508,000USD |
| Short Term Debt | 21,559,000USD | 15,104,000USD | 75,083,000USD | 291,572,000USD | 263,561,000USD | 248,991,000USD | 3,557,000USD | 95,272,000USD |
| Short Long Term Debt Total | 689,948,000USD | 686,247,000USD | 711,804,000USD | 422,961,000USD | 366,053,000USD | 275,416,000USD | 263,319,000USD | 95,272,000USD |
| Long Term Debt | 542,213,000USD | 525,567,000USD | 510,143,000USD | — | — | — | 232,767,000USD | 95,272,000USD |
| Short Term Investments | 201,607,000USD | 26,609,000USD | 0USD | 100,299,000USD | 0USD | — | — | 19,547,000USD |
| Net Receivables | 158,587,000USD | 134,115,000USD | 124,161,000USD | 116,247,000USD | 117,420,000USD | 71,389,000USD | 43,672,000USD | 16,062,000USD |
| Inventory | 170,458,000USD | 142,964,000USD | 202,321,000USD | 238,277,000USD | 184,494,000USD | 95,025,000USD | 54,832,000USD | 24,696,000USD |
| Accounts Payable | 30,010,000USD | 32,134,000USD | 19,563,000USD | 27,554,000USD | 36,203,000USD | 16,880,000USD | 11,425,000USD | 5,061,000USD |
| Property Plant Equipment Net | 306,152,000USD | 333,116,000USD | 322,955,000USD | 315,696,000USD | 226,523,000USD | 92,046,000USD | 74,162,000USD | 14,956,000USD |
| Property Plant Equipment Gross | 510,034,000USD | 495,583,000USD | 451,678,000USD | 408,003,000USD | 297,240,000USD | 92,046,000USD | 74,162,000USD | 14,956,000USD |
| Accumulated Other Comprehensive Income | -2,531,000USD | -52,533,000USD | -37,431,000USD | -34,394,000USD | -16,886,000USD | 2,085,000USD | -15,027,000USD | -13,749,000USD |
| Common Stock Shares Outstanding | 56,561,000shares | 55,937,000shares | 56,377,000shares | 57,455,000shares | 57,264,000shares | 53,892,000shares | 49,206,000shares | 34,099,000shares |
| Non Current Assets Total | 1,812,314,000USD | 1,763,625,000USD | 1,713,368,000USD | 1,533,482,000USD | 1,426,677,000USD | 1,000,505,000USD | 758,285,000USD | 104,760,000USD |
| Non Current Liabilities Total | 707,744,000USD | 730,161,000USD | 695,045,999USD | 216,704,000USD | 233,025,000USD | 54,781,000USD | 292,032,000USD | 99,074,000USD |
| Non Current Liabilities Other | 16,859,000USD | 36,243,000USD | 17,859,000USD | 186,762,000USD | 199,545,000USD | 27,749,000USD | 29,321,000USD | 3,802,000USD |
| Non Currrent Assets Other | 4,913,000USD | 868,000USD | 1,277,000USD | 815,000USD | 615,000USD | 573,000USD | 238,000USD | 450,000USD |
| Net Working Capital | 1,001,559,000USD | 939,254,000USD | 952,881,000USD | 593,922,000USD | 556,415,000USD | 583,426,000USD | 593,515,000USD | — |
| Unclassified Non Current Liabilities | 148,672,000USD | 168,351,000USD | 167,043,999USD | -71,431,000USD | -130,533,000USD | -28,356,000USD | -32,270,000USD | -3,802,000USD |
| Unclassified Equity | 1,651,286,000USD | 1,616,775,000USD | 1,568,669,000USD | 1,546,710,000USD | 1,571,787,000USD | 1,460,200,000USD | 1,067,910,000USD | 242,036,000USD |
| Other Assets | — | 282,077,000USD | — | 1,655,000USD | 2,518,000USD | 28,230,000USD | 3,158,000USD | 450,000USD |
| Unclassified Current Assets | — | -26,609,000USD | — | — | — | — | — | -18,560,000USD |
| Unclassified Non Current Assets | — | -281,328,000USD | — | — | — | -25,749,000USD | — | — |
| Short Long Term Debt | — | — | 69,452,000USD | 284,615,000USD | 255,258,000USD | 243,737,000USD | — | 95,272,000USD |
| Unclassified Current Liabilities | — | — | -62,638,000USD | -282,156,000USD | -250,274,000USD | -242,314,000USD | 3,874,000USD | -190,544,000USD |
| Deferred Long Term Liab | — | — | — | 23,000,000USD | 33,480,000USD | 27,032,000USD | 29,944,000USD | 0USD |
| Other Liab | — | — | — | 78,373,000USD | 130,533,000USD | 28,356,000USD | 32,270,000USD | 3,802,000USD |
| Net Tangible Assets | — | — | — | 701,511,000USD | 552,431,000USD | 623,745,000USD | 378,803,000USD | 79,410,000USD |
| Long Term Investments | — | — | — | — | — | — | — | 0USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 0USD |
| Treasury Stock | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 38,824,000USD |
| Stock Based Compensation | 16,335,000USD |
| Deferred Income Tax | -4,775,000USD |
| Other Non Cash Items | 1,815,000USD |
| Change To Account Receivables | -4,362,000USD |
| Change To Inventory | -20,158,000USD |
| Change To Liabilities | 7,075,000USD |
| Change In Working Capital | -22,476,000USD |
| Operating Cash Flow | 61,061,000USD |
| Capital Expenditures | -10,044,000USD |
| Net Investments | 1,302,000USD |
| Other Investing Activities | 0USD |
| Unclassified Investing Cash Flow | 2,665,000USD |
| Investing Cash Flow | -6,077,000USD |
| Net Common Stock Issuance | -6,612,000USD |
| Unclassified Financing Cash Flow | -5,131,000USD |
| Financing Cash Flow | -11,743,000USD |
| Effect Of Forex Changes On Cash | -456,000USD |
| Change In Cash | 42,785,000USD |
| End Cash Flow | 608,806,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 8,333,000USD | 13,287,000USD | 14,911,000USD | 14,866,000USD | 5,830,000USD | -33,869,000USD | -654,000USD | 3,321,000USD |
| Depreciation | 24,537,000USD | 24,592,000USD | 24,410,000USD | 24,766,000USD | 23,188,000USD | 35,256,000USD | 21,455,000USD | 16,757,000USD |
| Stock Based Compensation | 8,322,000USD | 7,984,000USD | 8,973,000USD | 8,375,000USD | 7,273,000USD | 6,359,000USD | 23,056,000USD | 9,214,000USD |
| Other Non Cash Items | 16,700,000USD | 1,784,000USD | -8,979,000USD | -5,897,000USD | 6,307,000USD | 10,410,000USD | 3,905,000USD | 3,951,000USD |
| Change To Account Receivables | 3,186,000USD | -9,863,000USD | 7,856,000USD | -5,237,000USD | -9,921,000USD | -9,400,000USD | -3,386,000USD | -7,898,000USD |
| Change To Inventory | -12,069,000USD | -9,601,000USD | -4,522,000USD | 3,004,000USD | -3,828,000USD | 36,764,000USD | 9,657,000USD | 7,307,000USD |
| Change In Working Capital | -21,897,000USD | -24,354,000USD | 11,999,000USD | -12,136,000USD | -26,389,000USD | 33,647,000USD | 1,968,000USD | 10,748,000USD |
| Total Cash From Operating Activities | 28,295,000USD | 25,704,000USD | 48,099,000USD | 28,609,000USD | 15,005,000USD | 39,176,000USD | 49,320,000USD | 42,190,000USD |
| Capital Expenditures | -4,947,000USD | -8,657,000USD | -5,386,000USD | -7,605,000USD | -4,430,000USD | -6,987,999USD | -7,138,000USD | -7,400,000USD |
| Free Cash Flow | 23,348,000USD | 17,047,000USD | 42,713,000USD | 21,004,000USD | 10,575,000USD | 32,188,000USD | 42,182,000USD | 34,790,000USD |
| Investments | 1,375,000USD | — | -7,783,000USD | -7,839,000USD | -74,108,000USD | -64,762,000USD | -5,859,000USD | -7,400,000USD |
| Total Cashflows From Investing Activities | -3,988,000USD | -208,744,000USD | -7,783,000USD | -7,839,000USD | -74,108,000USD | -64,762,000USD | -5,859,000USD | — |
| Total Cash From Financing Activities | -5,543,000USD | 195,000USD | -239,000USD | -10,131,000USD | -5,030,000USD | 1,449,000USD | -69,604,000USD | -5,773,000USD |
| Sale Purchase Of Stock | -5,543,000USD | -13,664,000USD | 7,170,000USD | -676,000USD | -6,494,000USD | -479,000USD | -1,235,000USD | -1,235,000USD |
| Change In Cash | 16,629,000USD | -182,726,000USD | 39,892,000USD | 11,626,000USD | -60,126,000USD | -26,609,000USD | -25,182,000USD | 28,529,000USD |
| Begin Period Cash Flow | 566,021,000USD | 748,747,000USD | 708,855,000USD | 697,229,000USD | 757,355,000USD | 783,964,000USD | 809,146,000USD | 780,617,000USD |
| End Period Cash Flow | 582,650,000USD | 566,021,000USD | 748,747,000USD | 708,855,000USD | 697,229,000USD | 757,355,000USD | 783,964,000USD | 809,146,000USD |
| Other Cashflows From Investing Activities | -416,000USD | 40,000USD | -2,397,000USD | -504,000USD | -825,000USD | 1,287,000USD | -11,000USD | — |
| Other Cashflows From Financing Activities | -5,543,000USD | 28,995,000USD | -917,000USD | -9,455,000USD | -6,494,000USD | -479,000USD | -243,000USD | -4,538,000USD |
| Unclassified Operating Cash Flow | -7,700,000USD | 2,411,000USD | -3,215,000USD | -1,365,000USD | -1,204,000USD | -12,627,000USD | — | -1,801,000USD |
| Unclassified Financing Cash Flow | 5,543,000USD | -15,136,000USD | -6,492,000USD | — | 7,958,000USD | 2,407,000USD | -68,126,000USD | — |
| Net Borrowings | — | 0USD | — | — | — | 0USD | — | — |
| Unclassified Investing Cash Flow | — | -200,127,000USD | 7,783,000USD | 8,109,000USD | 5,255,000USD | 5,700,999USD | 7,149,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 48,894,000USD | -25,514,000USD | 41,577,000USD | 185,959,000USD | 128,291,000USD | 59,926,000USD | 21,411,000USD | 16,617,000USD |
| Depreciation | 96,956,000USD | 86,562,000USD | 68,085,000USD | 57,012,000USD | 38,447,000USD | 27,067,000USD | 20,868,000USD | 15,778,000USD |
| Stock Based Compensation | 32,605,000USD | 48,070,000USD | 25,575,000USD | 27,316,000USD | 27,500,000USD | 17,007,000USD | 12,847,000USD | 10,192,000USD |
| Other Non Cash Items | -6,785,000USD | 22,145,000USD | -14,999,000USD | -27,014,000USD | 20,389,000USD | 11,971,000USD | 15,332,000USD | 4,245,000USD |
| Change To Account Receivables | -17,165,000USD | -14,031,000USD | -3,312,000USD | -3,596,000USD | -46,525,000USD | -20,892,000USD | -5,684,000USD | -6,101,000USD |
| Change To Inventory | -14,947,000USD | 56,895,000USD | 40,973,000USD | -57,204,000USD | -89,781,000USD | -29,994,000USD | -10,797,000USD | -4,042,000USD |
| Change In Working Capital | -50,880,000USD | 60,921,000USD | -8,637,000USD | -69,838,000USD | -102,128,000USD | -49,354,000USD | -2,618,000USD | -14,133,000USD |
| Total Cash From Operating Activities | 117,417,000USD | 175,394,000USD | 113,918,000USD | 172,083,000USD | 119,016,000USD | 62,625,000USD | 67,216,000USD | 32,770,000USD |
| Capital Expenditures | -23,519,000USD | -32,905,000USD | -38,988,000USD | -133,346,000USD | -67,089,000USD | -26,344,000USD | -23,154,000USD | -14,037,000USD |
| Free Cash Flow | 93,898,000USD | 142,489,000USD | 74,930,000USD | 38,737,000USD | 51,927,000USD | 36,281,000USD | 44,062,000USD | 18,733,000USD |
| Investments | -200,257,000USD | -86,383,000USD | -74,678,000USD | -100,000,000USD | -221,169,000USD | -201,385,000USD | -205,308,000USD | -14,037,000USD |
| Total Cashflows From Investing Activities | -298,474,000USD | -86,383,000USD | — | -233,236,000USD | -221,169,000USD | -201,385,000USD | -205,308,000USD | -14,037,000USD |
| Net Borrowings | 0USD | -69,939,000USD | 290,094,000USD | -26,000USD | -21,000USD | -21,000USD | 163,477,000USD | -11,000USD |
| Total Cash From Financing Activities | -15,205,000USD | -82,902,000USD | 248,961,000USD | -13,337,000USD | 961,000USD | 305,916,000USD | 484,867,000USD | 3,407,000USD |
| Sale Purchase Of Stock | 0USD | -14,386,000USD | -14,386,000USD | -17,018,000USD | -2,897,000USD | -10,000USD | -490,000USD | 3,418,000USD |
| Change In Cash | -191,334,000USD | 6,032,000USD | 227,865,001USD | -80,356,000USD | -113,478,000USD | 179,885,000USD | 343,585,000USD | 20,063,000USD |
| Begin Period Cash Flow | 757,355,000USD | 751,323,000USD | 523,457,999USD | 603,814,000USD | 717,292,000USD | 537,407,000USD | 193,822,000USD | 173,759,000USD |
| End Period Cash Flow | 566,021,000USD | 757,355,000USD | 751,323,000USD | 523,458,000USD | 603,814,000USD | 717,292,000USD | 537,407,000USD | 193,822,000USD |
| Other Cashflows From Investing Activities | -4,370,000USD | -5,941,000USD | — | -48,402,000USD | -4,187,000USD | -3,889,000USD | -4,650,000USD | -3,402,000USD |
| Other Cashflows From Financing Activities | -18,381,000USD | -17,257,000USD | -26,747,000USD | -17,044,000USD | -2,897,000USD | 8,141,000USD | 677,000USD | 3,418,000USD |
| Unclassified Operating Cash Flow | -3,373,000USD | -16,790,000USD | 2,317,000USD | — | 6,517,000USD | -3,992,000USD | — | — |
| Unclassified Investing Cash Flow | -70,328,000USD | 38,846,000USD | — | 48,512,000USD | 71,276,000USD | 30,233,000USD | 27,804,000USD | 17,439,000USD |
| Unclassified Financing Cash Flow | 3,176,000USD | 18,680,000USD | 565,682,000USD | 37,769,000USD | 9,673,000USD | 297,806,000USD | 321,693,000USD | -3,418,000USD |
| Dividends Paid | — | — | -565,682,000USD | -17,018,000USD | -2,897,000USD | — | -490,000USD | — |
| Change To Liabilities | — | — | — | -9,250,000USD | 41,295,000USD | 4,608,000USD | 13,739,000USD | 374,000USD |
| Issuance Of Capital Stock | — | — | — | 0USD | 0USD | 297,775,000USD | 320,713,000USD | 0USD |
| Cash And Cash Equivalents Changes | — | — | — | -74,490,000USD | -113,478,000USD | 179,885,000USD | 343,585,000USD | 20,063,000USD |
| Exchange Rate Changes | — | — | — | — | -12,286,000USD | 12,729,000USD | -3,190,000USD | -2,077,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Product | 204,085,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Royalty | 43,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 194,211,000 | USD | 0001193125-26-208954 |
| Q1 2026Quarterly · 2026-03-31 | Product | Royalty | 44,000 | USD | 0001193125-26-208954 |
| FY 2025Yearly · 2025-12-31 | Product | Chromatography Products | 153,176,000 | USD | 0001193125-26-076528 |
| FY 2025Yearly · 2025-12-31 | Product | Filtration Products | 402,792,000 | USD | 0001193125-26-076528 |
| FY 2025Yearly · 2025-12-31 | Product | Other Products | 3,320,000 | USD | 0001193125-26-076528 |
| FY 2025Yearly · 2025-12-31 | Product | Process Analytics Products | 81,237,000 | USD | 0001193125-26-076528 |
| FY 2025Yearly · 2025-12-31 | Product | Proteins Products | 97,435,000 | USD | 0001193125-26-076528 |
| FY 2025Yearly · 2025-12-31 | Product | Royalty | 296,000 | USD | 0001193125-26-076528 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 188,766,000 | USD | 0001193125-25-264666 |
| Q3 2025Quarterly · 2025-09-30 | Product | Royalty | 39,000 | USD | 0001193125-25-264666 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 182,329,000 | USD | 0000950170-25-105166 |
| Q2 2025Quarterly · 2025-06-30 | Product | Royalty | 37,000 | USD | 0000950170-25-105166 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 169,137,000 | USD | 0001193125-26-208954 |
| Q1 2025Quarterly · 2025-03-31 | Product | Royalty | 35,000 | USD | 0001193125-26-208954 |
| FY 2024Yearly · 2024-12-31 | Product | Chromatography Products | 122,810,000 | USD | 0001193125-26-076528 |
| FY 2024Yearly · 2024-12-31 | Product | Filtration Products | 372,963,000 | USD | 0001193125-26-076528 |
| FY 2024Yearly · 2024-12-31 | Product | Other Products | 4,679,000 | USD | 0001193125-26-076528 |
| FY 2024Yearly · 2024-12-31 | Product | Process Analytics Products | 59,301,000 | USD | 0001193125-26-076528 |
| FY 2024Yearly · 2024-12-31 | Product | Proteins Products | 74,425,000 | USD | 0001193125-26-076528 |
| FY 2024Yearly · 2024-12-31 | Product | Royalty | 261,000 | USD | 0001193125-26-076528 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 154,834,000 | USD | 0001193125-25-264666 |
| Q3 2024Quarterly · 2024-09-30 | Product | Royalty | 37,000 | USD | 0001193125-25-264666 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product | 158,804,000 | USD | 0000950170-25-105166 |
| Q2 2024Quarterly · 2024-06-30 | Product | Royalty | 35,000 | USD | 0000950170-25-105166 |
| Q1 2024Quarterly · 2024-03-31 | Product | Product | 153,146,000 | USD | 0000950170-25-060156 |
| Q1 2024Quarterly · 2024-03-31 | Product | Royalty | 36,000 | USD | 0000950170-25-060156 |
| FY 2023Yearly · 2023-12-31 | Product | Chromatography Products | 126,629,000 | USD | 0001193125-26-076528 |
| FY 2023Yearly · 2023-12-31 | Product | Filtration Products | 341,379,000 | USD | 0001193125-26-076528 |
| FY 2023Yearly · 2023-12-31 | Product | Other Products | 3,688,000 | USD | 0001193125-26-076528 |
| FY 2023Yearly · 2023-12-31 | Product | Process Analytics Products | 56,820,000 | USD | 0001193125-26-076528 |
| FY 2023Yearly · 2023-12-31 | Product | Proteins Products | 103,463,000 | USD | 0001193125-26-076528 |
| FY 2023Yearly · 2023-12-31 | Product | Royalty | 383,000 | USD | 0001193125-26-076528 |
| FY 2022Yearly · 2022-12-31 | Product | Chromatography Products | 131,680,000 | USD | 0000950170-25-038999 |
| FY 2022Yearly · 2022-12-31 | Product | Filtration Products | 495,930,000 | USD | 0000950170-25-038999 |
| FY 2022Yearly · 2022-12-31 | Product | Other Products | 5,741,000 | USD | 0000950170-25-038999 |
| FY 2022Yearly · 2022-12-31 | Product | Process Analytics Products | 53,512,000 | USD | 0000950170-25-038999 |
| FY 2022Yearly · 2022-12-31 | Product | Proteins Products | 114,320,000 | USD | 0000950170-25-038999 |
| FY 2022Yearly · 2022-12-31 | Product | Royalty | 353,000 | USD | 0000950170-25-038999 |
| FY 2021Yearly · 2021-12-31 | Product | Chromatography Products | 91,037,000 | USD | 0000950170-23-003793 |
| FY 2021Yearly · 2021-12-31 | Product | Filtration Products | 403,505,000 | USD | 0000950170-23-003793 |
| FY 2021Yearly · 2021-12-31 | Product | Other Products | 4,051,000 | USD | 0000950170-23-003793 |
| FY 2021Yearly · 2021-12-31 | Product | Process Analytics Products | 48,019,000 | USD | 0000950170-23-003793 |
| FY 2021Yearly · 2021-12-31 | Product | Proteins Products | 123,707,000 | USD | 0000950170-23-003793 |
| FY 2021Yearly · 2021-12-31 | Product | Royalty | 215,000 | USD | 0000950170-23-003793 |
| FY 2020Yearly · 2020-12-31 | Product | Chromatography Products | 70,677,000 | USD | 0000950170-23-003793 |
| FY 2020Yearly · 2020-12-31 | Product | Filtration Products | 174,851,000 | USD | 0000950170-23-003793 |
| FY 2020Yearly · 2020-12-31 | Product | Other Products | 3,945,000 | USD | 0000950170-23-003793 |
| FY 2020Yearly · 2020-12-31 | Product | Process Analytics Products | 33,346,000 | USD | 0000950170-23-003793 |
| FY 2020Yearly · 2020-12-31 | Product | Proteins Products | 83,317,000 | USD | 0000950170-23-003793 |
| FY 2020Yearly · 2020-12-31 | Product | Royalty | 124,000 | USD | 0000950170-23-003793 |
| FY 2019Yearly · 2019-12-31 | Product | Chromatography Products | 60,662,000 | USD | 0000950170-22-001430 |
| FY 2019Yearly · 2019-12-31 | Product | Filtration Products | 119,464,000 | USD | 0000950170-22-001430 |
| FY 2019Yearly · 2019-12-31 | Product | Other Products | 4,562,000 | USD | 0000950170-22-001430 |
| FY 2019Yearly · 2019-12-31 | Product | Process Analytics Products | 16,405,000 | USD | 0000950170-22-001430 |
| FY 2019Yearly · 2019-12-31 | Product | Proteins Products | 69,004,000 | USD | 0000950170-22-001430 |
| FY 2019Yearly · 2019-12-31 | Product | Royalty | 148,000 | USD | 0000950170-22-001430 |
| FY 2018Yearly · 2018-12-31 | Product | Chromatography Products | 45,326,000 | USD | 0001193125-21-054675 |
| FY 2018Yearly · 2018-12-31 | Product | Filtration Products | 90,586,000 | USD | 0001193125-21-054675 |
| FY 2018Yearly · 2018-12-31 | Product | Other Products | 3,604,000 | USD | 0001193125-21-054675 |
| FY 2018Yearly · 2018-12-31 | Product | Proteins Products | 54,375,000 | USD | 0001193125-21-054675 |
| FY 2018Yearly · 2018-12-31 | Product | Royalty | 141,000 | USD | 0001193125-21-054675 |
| Q3 2018Quarterly · 2018-09-30 | Geography | All Other | 62,000 | USD | 0001193125-18-315604 |
| Q3 2018Quarterly · 2018-09-30 | Geography | Asia And Australia | 6,075,000 | USD | 0001193125-18-315604 |
| Q3 2018Quarterly · 2018-09-30 | Geography | Europe | 19,328,000 | USD | 0001193125-18-315604 |
| Q3 2018Quarterly · 2018-09-30 | Geography | North America | 24,064,000 | USD | 0001193125-18-315604 |
| Q2 2018Quarterly · 2018-06-30 | Geography | All Other | 55,000 | USD | 0001193125-18-236196 |
| Q2 2018Quarterly · 2018-06-30 | Geography | Asia And Australia | 5,617,000 | USD | 0001193125-18-236196 |
| Q2 2018Quarterly · 2018-06-30 | Geography | Europe | 19,578,000 | USD | 0001193125-18-236196 |
| Q2 2018Quarterly · 2018-06-30 | Geography | North America | 22,481,000 | USD | 0001193125-18-236196 |
| Q1 2018Quarterly · 2018-03-31 | Geography | All Other | 243,000 | USD | 0001193125-18-155618 |
| Q1 2018Quarterly · 2018-03-31 | Geography | Asia Pacific | 4,947,000 | USD | 0001193125-18-155618 |
| Q1 2018Quarterly · 2018-03-31 | Geography | Europe | 19,401,000 | USD | 0001193125-18-155618 |
| Q1 2018Quarterly · 2018-03-31 | Geography | North America | 20,239,000 | USD | 0001193125-18-155618 |
| Q3 2017Quarterly · 2017-09-30 | Geography | All Other | 148,000 | USD | 0001193125-18-315604 |
| Q3 2017Quarterly · 2017-09-30 | Geography | Asia And Australia | 3,630,000 | USD | 0001193125-18-315604 |
| Q3 2017Quarterly · 2017-09-30 | Geography | Europe | 16,374,000 | USD | 0001193125-18-315604 |
| Q3 2017Quarterly · 2017-09-30 | Geography | North America | 16,428,000 | USD | 0001193125-18-315604 |
| Q2 2017Quarterly · 2017-06-30 | Geography | All Other | 259,000 | USD | 0001193125-18-236196 |
| Q2 2017Quarterly · 2017-06-30 | Geography | Asia And Australia | 3,604,000 | USD | 0001193125-18-236196 |
| Q2 2017Quarterly · 2017-06-30 | Geography | Europe | 16,155,000 | USD | 0001193125-18-236196 |
| Q2 2017Quarterly · 2017-06-30 | Geography | North America | 12,437,000 | USD | 0001193125-18-236196 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.